Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Nikvailo
    Member
    • Apr 2013
    • 15

    #1

    Possible Cause for False Homozygous Reads (Heterozygous in Real)

    While we sequencing CFTR with long-range PCR + Nextera XT + MiSeq 2x250bp, we detected homozygous variant in sample. (upper part of image)

    However, when we sequenced the same sample with short-range PCR with same conditions, the variant seemed heterozygous. (lower part of image)

    What could be the reason for that?

    Is it possible that our long-range primers bind and amplify only one copy of CFTR?

  • Brian Bushnell
    Super Moderator
    • Jan 2014
    • 2709

    #2
    Certainly, if your SNP of interest is linked to another mutation that happens to be at your primer site, you'll get a major bias. Perhaps you should examine both of your long-amplicon primer sites with Sanger.

    Comment

    • ECO
      --Site Admin--
      • Oct 2007
      • 1360

      #3
      I also have run into a situation where Illumina's adapter trimming was too promiscuous, and was actually trimming regions of the genome!

      Ha! I just found my old example and it was CFTR also (albeit exon 10):

      Bridged amplification & clustering followed by sequencing by synthesis. (Genome Analyzer / HiSeq / MiSeq)


      How did you do adapter trimming? Are you able to visualize soft-clipped reads?

      Comment

      • HESmith
        Senior Member
        • Oct 2009
        • 512

        #4
        Another possibility is that the exon 3 sequence is duplicated in your genome, and the short-range (but not long-range) PCR primers are amplifying both copies.

        Comment

        • Richard Finney
          Senior Member
          • Feb 2009
          • 701

          #5
          Are other exons in your target?
          What's the coverage of the other exons relative to exon 3 ?

          Comment

          • Nikvailo
            Member
            • Apr 2013
            • 15

            #6
            Thank you for all answers. And sorry for my late reply. We were quite busy.

            Originally posted by Brian Bushnell View Post
            Certainly, if your SNP of interest is linked to another mutation that happens to be at your primer site, you'll get a major bias. Perhaps you should examine both of your long-amplicon primer sites with Sanger.
            Thank you Brian. It is quite possible. We will design primers to check that if there is any variant in the primer binding site.

            Originally posted by ECO
            I also have run into a situation where Illumina's adapter trimming was too promiscuous, and was actually trimming regions of the genome!
            Ha! I just found my old example and it was CFTR also (albeit exon 10):
            Bridged amplification & clustering followed by sequencing by synthesis. (Genome Analyzer / HiSeq / MiSeq)

            How did you do adapter trimming? Are you able to visualize soft-clipped reads?
            We are actually using MiSeq built-in adapter trimming option. I understand you example. I is very strange that, that trimmer can also remove genomic regions. But I couldn't figure out that how such bug results with my problem?

            Originally posted by HESmith
            IAnother possibility is that the exon 3 sequence is duplicated in your genome, and the short-range (but not long-range) PCR primers are amplifying both copies.
            So you say that one of duplicated exon has variant but other has not? Right?

            Originally posted by Richard Finney
            Are other exons in your target?
            What's the coverage of the other exons relative to exon 3 ?
            It changes. Because of that the PCR efficiency of each amplicon is different the coverage is different in each of exonic regions.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM
            • SEQadmin2
              New Genomics Technologies Take Aim at Long-Standing Limits
              by SEQadmin2


              Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

              We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
              ...
              09-28-2026, 10:25 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 10-22-2026, 11:13 AM
            0 responses
            60 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-22-2026, 10:48 AM
            0 responses
            42 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-15-2026, 10:52 AM
            0 responses
            75 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-14-2026, 05:39 AM
            0 responses
            74 views
            0 reactions
            Last Post SEQadmin2  
            Working...